0RPS.LSE Medicover AB Series B

Healthcare Commercial Services & Supplies London Exchange
207.49 SEK
Close of Nov 3, 2026
177.73 284.00
Market cap
SEK 27.7B
P/E
465.5x
P/B
-
ROE
17.0%
Dividend yield
0.68%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0RPS.LSE undervalued?

Graham number

The Graham number of Medicover AB Series B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medicover AB Series B fundamental analysis

No fundamental analysis for Medicover AB Series B yet.

Medicover AB Series B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medicover AB Series B

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hos…

Full company profile